Association between glycogen synthase kinase-3β gene polymorphisms and major depression and suicidal behavior in a Korean population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 2, 2010, Pages 331-334

  Yoon, Ho Kyoung ^a   Kim, Yong Ku ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Depression; GSK 3 ; Polymorphism; Suicide

Indexed keywords

ADENOSINE; CYTIDINE; GLYCOGEN SYNTHASE KINASE 3BETA; THYMIDINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION RESEARCH; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; TREND STUDY;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SUICIDE;

EID: 77649272940     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.12.009     Document Type: Article

References (33)

1. Bauer M., Adli M., Baethge C., Berghofer A., Sasse J., Heinz A., et al. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can J Psychiatry 2003, 48:440-448.
2. Beaulieu J.-M., Sotnikova T.D., Yao W.-D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 2004, 101:5099-5104.
3. Beaulieu J.-M., Zhang X., Rodriguiz R., Sotnikova T., Cools M., Wetsel W., et al. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A 2008, 105:1333-1338.
4. Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 2004, 368:123-126.
5. Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50T/C SNP. Neurosci Lett 2005, 376:51-55.
6. D'Sa C., Duman R. Antidepressants and neuroplasticity. Bipolar Disord 2002, 4:183-194.
7. Dwivedi Y., Rao J., Rizavi H., Kotowski J., Conley R., Roberts R., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:273-282.
8. Dwivedi Y., Rizavi H., Shukla P., Lyons J., Faludi G., Palkovits M., et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 2004, 55:234-243.
9. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004, 36:131-137.
10. Embi N, Rylatt D.B., Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980, 107:519-527.
11. Frame S., Cohen P., Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001, 7:1321-1327.
12. Gil M., Zhen X., Friedman E. Prenatal cocaine exposure alters glycogen synthase kinase-3beta (GSK3beta) pathway in select rabbit brain areas. Neurosci Lett 2003, 349:143-146.
13. Gross-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 1998, 22:653-661.
14. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29:95-102.
15. Karege F., Perroud N., Burkhardt S., Schwald M., Ballmann E., La Harpe R., et al. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 2007, 61:240-245.
16. Kim Y.K., Won S.D., Hur J.W., Lee B.H., Lee H.Y., Shim S.H., et al. Exploration of biological markers of suicidal behavior in major depressive disorder. Psychiatry Invest 2007, 4:13-21.
17. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996, 93:8455-8459.
18. Lee B.H., Kim Y.K. Neurobiological factors associated with suicidal behavior. Psychiatry Invest 2006, 3:23-35.
19. Lee K.Y., Ahn Y.M., Joo E.J., Jeong S.H., Chang J.S., Kim S.C., et al. No association of two common SNPs at position -1727A/T, -50C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 2006, 395:175-178.
20. Li X., Zhu W., Roh M.-S., Friedman A., Rosborough K., Jope R. In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004, 29:1426-1431.
21. Nishiguchi N, Breen G, Russ C, St Clair D, Collier D Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder. Neurosci Lett 2006, 394:243-245.
22. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 1996, 723:37-45.
23. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Conley R.R. Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch Gen Psychiatry 2004, 61:685-693.
24. Pandey G.N., Dwivedi Y., Rizavi H.S., Teppen T., Gaszner G.L., Roberts R.C., et al. GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide. Neurochem Res 2009, 34:274-285.
25. Roh M.S., Eom T.Y., Zmijewska A., De Sarno P., Roth K., Jope R. Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol Psychiatry 2005, 57:278-286.
26. Russ C., Lovestone S., Powell J.F. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol Psychiatry 2001, 6:320-324.
27. Scassellati C., Bonvicini C., Perez J., Bocchio-Chiavetto L., Tura G.B., Rossi G., et al. Association study of -1727A/T, -50C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia. Neuropsychobiology 2004, 50:16-20.
28. Shaw P.C., Davies A.F., Lau K.F., Garcia-Barcelo M., Waye M.M., Lovestone S., et al. Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 1998, 41:720-727.
29. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996, 6:1664-1668.
30. Szczepankiewicz A., Skibinska M., Hauser J., Slopien A., Leszczynska-Rodziewicz A., Kapelski P., et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 2006, 53:51-56.
31. Tsai S.J., Liou Y.J., Hong C.J., Yu Y.W.Y., Chen T.J. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Pharmacogenomics J 2008, 8:384-390.
32. Yoon H.K., Kim Y.K. Association between serotonin-related gene polymorphisms and suicidal behavior in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1293-1297.
33. Yoon H.K., Kim Y.K. TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:403-409.